Identification of potential SARS-CoV-2 entry inhibitors by targeting the interface region between the spike RBD and human ACE2 (original) (raw)
Arun B Gurung2021, Journal of Infection and Public Health
visibility
…
description
12 pages
link
1 file
Related papers
Informatics in Medicine Unlocked, 2020
Current targets and drug candidates for prevention and treatment of SARS-CoV-2 (COVID-19) infection
Reviews in Cardiovascular Medicine, 2020
Discovering small-molecule therapeutics against SARS-CoV-2
Drug Discovery Today, 2020
Blockers of the SARS-CoV-2 3a Channel Identified by Targeted Drug Repurposing
Viruses, 2021
Frontiers in Oncology, 2020
Previous and potential mutations of Sars-cov-2 receptors and their interaction with known inhibitors
GSC biological and pharmaceutical sciences, 2023
Cellular Signalling, 2020
Chemical Papers, 2021
Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2
Cellular & Molecular Immunology
Journal of Molecular Modeling, 2022
Loading Preview
Sorry, preview is currently unavailable. You can download the paper by clicking the button above.
Related papers
In silico identification of SARS-CoV-2 cell entry inhibitors from selected natural antivirals
Journal of Molecular Graphics and Modelling, 2021
Identification of SARS-CoV-2 inhibitors using lung and colonic organoids
Nature, 2020
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
Nature, 2020
Open Journal of Proteomics and Genomics, 2021
OVERVIEW OF ANTIVIRAL DRUGS AGAINST SARS-CoV-2 FOR THE TREATMENT OF COVID-19
Acta Medica Medianae, 2021
SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity
Cell Host & Microbe, 2021
An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies
Cell, 2021
Computational Determination of Potential Inhibitors of SARS-CoV2 Main Protease
bioRxiv (Cold Spring Harbor Laboratory), 2021
European Journal of Pharmacology, 2021
A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor
Drugs in R&D
Potential SARS-CoV-2 Spike Protein-ACE2 Interface Inhibitors: Repurposing FDA-approved Drugs
Journal of Exploratory Research in Pharmacology, 2022
The Repurposed ACE2 Inhibitors: SARS-CoV-2 Entry Blockers of Covid-19
Topics in Current Chemistry, 2021
In Silico Study Of Natural Compound Candidates As Promising Drugs For SARS-Cov-2
International Journal of Scientific & Technology Research, 2021
A potential peptide inhibitor of SARS-CoV-2 S and human ACE2 complex
Journal of Biomolecular Structure and Dynamics
Virology, 2006
Using in vivo animal models for studying SARS-CoV-2
Expert Opinion on Drug Discovery, 2021
Molecular modelling studies to suggest novel scaffolds against SARS-CoV-2 target enzymes
Journal of research in pharmacy, 2021
ERJ Open Research, 2021
Discovery and evaluation of entry inhibitors for SARS-CoV-2 and its emerging variants
Journal of Virology
ACE-2 receptors blockers: A novel therapeutic line of attack against COVID-19
INTERNATIONAL JOURNAL OF PHARMACOLOGY AND THERAPEUTICS, 2020
Insights into the Interaction of SARS-COV-2 with ACE 2 Receptor
2021
Recent advances in computational drug discovery for therapy against coronavirus SARS-CoV-2
ScienceRise. Pharmaceutical science, 2023
3 Biotech